Literature DB >> 10999830

Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

J P Bastard1, C Jardel, E Bruckert, P Blondy, J Capeau, M Laville, H Vidal, B Hainque.   

Abstract

The aim of this study was to investigate the potential role of adipose cytokines in the obesity-associated insulin resistance. To that end, we compared: 1) serum concentrations of interleukin 6 (IL-6), tumor necrosis factor alpha (TNFalpha), and leptin in eight healthy lean control females and in android obese female without (n = 14) and with (n = 7) type 2 diabetes; and 2) the levels of these cytokines both in serum and in sc adipose tissue in the 14 obese nondiabetic women before and after 3 weeks of a very low-calorie diet (VLCD). As compared with lean controls, obese nondiabetic and diabetic patients were more insulin resistant and presented increased values for leptin, IL-6, TNFalpha, and C-reactive protein. In the whole group, IL-6 values were more closely related to the parameters evaluating insulin resistance than leptin or TNFalpha values. VLCD resulted in weight loss and decreased body fat mass (approximately 3 kg). Insulin sensitivity was improved with no significant change in both serum and adipose tissue TNFalpha levels. In contrast, VLCD induced significant decreases in IL-6 and leptin levels in both adipose tissue and serum. These results suggest that, as for leptin, circulating IL-6 concentrations reflect, at least in part, adipose tissue production. The reduced production and serum concentrations after weight loss could play a role in the improved sensitivity to insulin observed in these patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999830     DOI: 10.1210/jcem.85.9.6839

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  252 in total

Review 1.  Vascular inflammation as a therapeutic target for prevention of cardiovascular disease.

Authors:  Luther T Clark
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

2.  Principal component 1 score calculated from metabolic syndrome diagnostic parameters is a possible marker for the development of metabolic syndrome in middle-aged Japanese men without treatment for metabolic diseases.

Authors:  Kazuki Mochizuki; Rie Miyauchi; Yasumi Misaki; Yoko Ichikawa; Toshinao Goda
Journal:  Eur J Nutr       Date:  2011-12-09       Impact factor: 5.614

Review 3.  Obesity, cytokines and endothelial dysfunction: a link for the raised cardiovascular risk associated with visceral obesity.

Authors:  K Esposito; G Nicoletti; D Giugliano
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

Review 4.  Interleukin-6 and insulin sensitivity: friend or foe?

Authors:  A L Carey; M A Febbraio
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

5.  Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.

Authors:  Christopher Johnson; Yuyan Han; Nathan Hughart; Jennifer McCarra; Gianfranco Alpini; Fanyin Meng
Journal:  Transl Gastrointest Cancer       Date:  2012-04-01

Review 6.  Beyond BMI: Obesity and Lung Disease.

Authors:  Ubong Peters; Benjamin T Suratt; Jason H T Bates; Anne E Dixon
Journal:  Chest       Date:  2017-07-17       Impact factor: 9.410

Review 7.  Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes.

Authors:  Milagros G Huerta; Jerry L Nadler
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 8.  Interleukin-6: designing specific therapeutics for a complex cytokine.

Authors:  Christoph Garbers; Sylvia Heink; Thomas Korn; Stefan Rose-John
Journal:  Nat Rev Drug Discov       Date:  2018-05-04       Impact factor: 84.694

9.  Interleukin-6 receptor gene 48892 A/C polymorphism is associated with metabolic syndrome in female Taiwanese adolescents.

Authors:  Chang-Hsun Hsieh; Yi-Jen Hung; Ling-I Wu; Chih-Tsueng He; Chien-Hsing Lee; Fone-Ching Hsiao; Nain-Feng Chu
Journal:  Genet Test Mol Biomarkers       Date:  2012-10-24

Review 10.  Adipose tissue inflammation in glucose metabolism.

Authors:  H L Kammoun; M J Kraakman; M A Febbraio
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.